These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 4327089

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Immunologic response to transplantable specific antigens in experimental tumors].
    Porwit-Bóbr Z.
    Postepy Hig Med Dosw; 1971; 25(1):25-36. PubMed ID: 4932042
    [No Abstract] [Full Text] [Related]

  • 27. Humoral cytotoxic factor in isograft immunity against azo-dye induced hepatoma.
    el-Asfahani AM, Maruta H, Mizuno D, Ishidate M, Hashimoto Y.
    Jpn J Exp Med; 1973 Dec; 43(6):545-8. PubMed ID: 4361511
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B.
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract] [Full Text] [Related]

  • 30. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
    Egusa K.
    Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Regulation of immunity toward allogeneic tumors in mice. I. Effect of antiserum fractions on tumor growth.
    Takasugi M, Hildemann WH.
    J Natl Cancer Inst; 1969 Oct; 43(4):843-56. PubMed ID: 5344181
    [No Abstract] [Full Text] [Related]

  • 35. Ehancement and hyperacute rejection of skin grafts in the mousefailure to separate cytotoxic and enhancing antibodies from alloantiserum with physicochemical methods.
    Jansen JL, Koene RA, Kamp GJ, Gerlag PG, Wijdeveld PA.
    J Immunol; 1975 May; 114(5):1557-62. PubMed ID: 804518
    [Abstract] [Full Text] [Related]

  • 36. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM, Whitten HD, Lewis GK, Watson ES.
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antibodies bound to the lymph node cells. II. Detection of the antibodies on the surface of the lymph node cells.
    Fujii G, Goto S, Nishihira T, Ishibashi Y.
    Jpn J Exp Med; 1971 Aug; 41(4):299-309. PubMed ID: 4936581
    [No Abstract] [Full Text] [Related]

  • 39. Acceptance of phenotypically differing cultured skin in man and mice.
    Summerlin WT, Broutbar C, Foanes RB, Payne R, Stutman O, Hayflick L, Good RA.
    Transplant Proc; 1973 Mar; 5(1):707-10. PubMed ID: 4633094
    [No Abstract] [Full Text] [Related]

  • 40. The specificity of effector T cells activated by tumours induced by murine oncornaviruses.
    Shellam GR, Knight RA, Mitchison NA, Gorczynski RM, Maoz A.
    Transplant Rev; 1976 Mar; 29():249-76. PubMed ID: 58459
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.